These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15823269)

  • 21. [Association of carotid atherosclerosis with coronary artery disease: comparison between carotid ultrasonography and coronary angiography in patients with chest pain].
    Novo S; Corrado E; Novo G; Dell'Oglio S
    G Ital Cardiol (Rome); 2012 Feb; 13(2):118-23. PubMed ID: 22322552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent clinical studies of the effects of lipid-modifying therapies.
    Gotto AM; Moon JE
    Am J Cardiol; 2012 Jul; 110(1 Suppl):15A-26A. PubMed ID: 22697388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS).
    Van Mieghem CA; McFadden EP; de Feyter PJ; Bruining N; Schaar JA; Mollet NR; Cademartiri F; Goedhart D; de Winter S; Granillo GR; Valgimigli M; Mastik F; van der Steen AF; van der Giessen WJ; Sianos G; Backx B; Morel MA; van Es GA; Zalewski A; Serruys PW
    J Am Coll Cardiol; 2006 Mar; 47(6):1134-42. PubMed ID: 16545642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Workshop VI--Regression of atherosclerosis: what does it mean?
    Brown BG
    Am J Med; 1991 Feb; 90(2A):53S-55S. PubMed ID: 1994718
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention or reversal of atherosclerosis: review of current evidence.
    Blankenhorn DH
    Am J Cardiol; 1989 May; 63(16):38H-41H. PubMed ID: 2650523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Form to function: current and future roles for atherosclerosis imaging in drug development.
    Lindsay AC; Choudhury RP
    Nat Rev Drug Discov; 2008 Jun; 7(6):517-29. PubMed ID: 18483481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood glucose variability: a new metric for interventional cardiology?
    Farkouh ME
    JACC Cardiovasc Interv; 2015 May; 8(6):812-813. PubMed ID: 25999103
    [No Abstract]   [Full Text] [Related]  

  • 28. Antioxidant intake and coronary atherosclerosis: consider a "foods first" approach.
    Hyson DA
    Prev Cardiol; 2006; 9(2):73-4. PubMed ID: 16603824
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase III and Phase IV trials: noninvasive assessment of efficacy endpoints in vessel walls.
    Levenson J; Simon A
    Am J Cardiol; 1998 Apr; 81(8A):67F-68F. PubMed ID: 9604914
    [No Abstract]   [Full Text] [Related]  

  • 30. Regression of coronary atherosclerosis: is it possible?
    Shepherd J; Packard CJ
    Br Heart J; 1988 Feb; 59(2):149-50. PubMed ID: 3342156
    [No Abstract]   [Full Text] [Related]  

  • 31. Translational atherosclerosis research: From experimental models to coronary artery disease in humans.
    Gleissner CA
    Atherosclerosis; 2016 May; 248():110-6. PubMed ID: 26999293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventive cardiology.
    Foody JA
    Curr Opin Cardiol; 1999 Sep; 14(5):382-91. PubMed ID: 10500900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease.
    Nidorf SM; Layland J; Robinson PC; Patel S; Psaltis PJ; Thompson PL
    Med J Aust; 2022 May; 216(8):385-387. PubMed ID: 35393699
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy.
    Cattaneo M; Froio A; Gallino A
    Eur Cardiol; 2019 Apr; 14(1):62-64. PubMed ID: 31131039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in medical polyesters for vascular tissue engineering.
    Mi CH; Qi XY; Zhou YW; Ding YW; Wei DX; Wang Y
    Discov Nano; 2024 Aug; 19(1):125. PubMed ID: 39115796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression and Stabilization of Coronary Vulnerable Plaque by Evolocumab as Assessed by Multidetector Row Computed Tomography.
    Shiga Y; Idemoto Y; Tashiro K; Imaizumi T; Ueda Y; Yano Y; Norimatsu K; Nakamura A; Miura SI
    Intern Med; 2020 Oct; 59(19):2391-2395. PubMed ID: 32611955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis.
    Wu Z; Chen C; Zhang B; Tang L; Shi W; Liao D; Di G; Davis JR; Wang H
    Int J Nanomedicine; 2019; 14():2609-2618. PubMed ID: 31043777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regression of coronary plaque after coronary artery bypass graft.
    Shiga Y; Miura SI; Nishikawa H; Nakamura A; Arimura T; Mitsutake R; Iwata A; Saku K
    J Cardiol Cases; 2012 Apr; 5(2):e92-e95. PubMed ID: 30532913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piecewise Pulse Wave Imaging (pPWI) for Detection and Monitoring of Focal Vascular Disease in Murine Aortas and Carotids In Vivo.
    Apostolakis IZ; Nandlall SD; Konofagou EE
    IEEE Trans Med Imaging; 2016 Jan; 35(1):13-28. PubMed ID: 26168432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Techniques for phenotyping coronary artery disease in the cardiac catheterization laboratory for applications in translational research.
    Ragosta M
    J Cardiovasc Transl Res; 2011 Aug; 4(4):385-92. PubMed ID: 21445697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.